# TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir

> **NCT01205139** · PHASE1 · COMPLETED · sponsor: **Tibotec Pharmaceuticals, Ireland** · enrollment: 48 (actual)

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** TMC435
- **DRUG:** TDF
- **DRUG:** TMC435 + TDF
- **DRUG:** TMC435 + TMC278
- **DRUG:** TMC278
- **DRUG:** TMC435

## Key facts

- **NCT ID:** NCT01205139
- **Lead sponsor:** Tibotec Pharmaceuticals, Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01205139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01205139, "TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01205139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*